Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
Enveda Biosciences has raised $150.0M in total funding. The most recent round was Series D. The last funding was announced in September 2025.
Enveda Biosciences's investors include FPV Ventures, Village Global, Lux Capital, Sanofi, Catalio Capital Management.
Enveda Biosciences is headquartered in Boulder, United States.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
Enveda Biosciences is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enveda Biosciences — Funding & Investors." VCBacked, September 4, 2025, https://www.vcbacked.co/company/enveda-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Enveda Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/enveda-biosciences
{{cite web |title=Enveda Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/enveda-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated